Table 2 Basic information of different mediastinal lesions and CTCs levels in the whole cohort
Characteristics | Training cohort n = 434 | Validation cohort n = 288 | Test cohort n = 352 | CTCs level (pg/ml) |
|---|---|---|---|---|
Benign | ||||
Cyst | 162 | 54 | 90 | 10.38 ± 4.44 |
Granuloma | 3 | 6 | 14 | 13.24 ± 5.57 |
Mature teratoma | 8 | 7 | 3 | 9.85 ± 2.08 |
Schwannoma | 32 | 17 | 34 | 11.97 ± 5.29 |
Fibroma | 11 | 4 | 10 | 14.77 ± 5.52 |
Hemangioma | 4 | 2 | 5 | 11.22 ± 2.83 |
Lipoma | 10 | 3 | 6 | 12.73 ± 4.39 |
Malignant | ||||
Type A thymoma | 9 | 15 | 21 | 11.13 ± 4.32 |
Type AB thymoma | 42 | 31 | 39 | 13.78 ± 6.51 |
Type B1 thymoma | 15 | 29 | 26 | 14.84 ± 3.04 |
Type B2 thymoma | 29 | 21 | 15 | 12.43 ± 6.23 |
Type B3 thymoma | 13 | 10 | 13 | 14.04 ± 2.78 |
Mixed thymoma | 13 | 19 | 17 | 13.50 ± 7.13 |
TSCC | 28 | 13 | 18 | 15.89 ± 7.75 |
Immature teratoma | 7 | 9 | 4 | 14.38 ± 5.42 |
MALT | 4 | 5 | 3 | 21.66 ± 4.09 |
Carcinoid | 2 | 4 | 5 | 9.86 ± 0.67 |
Lymphoma | 18 | 22 | 14 | 16.25 ± 6.36 |
Metastatic tumor | 5 | 3 | 4 | 11.38 ± 5.81 |
Others | 19 | 14 | 11 | 16.33 ± 4.62 |